DNA editing of LTR retrotransposons reveals the impact of APOBECs on vertebrate genomes

Molecular Biology and Evolution

Volumn 33, Issue 2, 2016, Pages 554-567

  Knisbacher, Binyamin A ^a   Levanon, Erez Y ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

apobec; apobec3; DNA editing; genome evolution; innate immunity; retrotransposons

Indexed keywords

DNA STRUCTURE; ENDOGENOUS RETROVIRUS; EXON; INNATE IMMUNITY; LONG TERMINAL REPEAT; MARSUPIAL; MUTATIONAL LOAD; OPEN READING FRAME; PLACENTAL MAMMALS; PREVALENCE; PROBABILITY; PROMOTER REGION; RETROPOSON; SPECIES; TAENIOPYGIA GUTTATA; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; VERTEBRATE; ANIMAL; BIOLOGY; CLUSTER ANALYSIS; GENETICS; GENOME; HUMAN; MOLECULAR EVOLUTION; NUCLEOTIDE MOTIF; POSITION WEIGHT MATRIX; PROCEDURES; TRANSPOSON;

APOBEC1 PROTEIN, HUMAN; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; CYTIDINE DEAMINASE; RETROPOSON; TRANSPOSON;

ANIMALS; APOBEC-1 DEAMINASE; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; CYTIDINE DEAMINASE; DNA TRANSPOSABLE ELEMENTS; EVOLUTION, MOLECULAR; GENOME; HUMANS; NUCLEOTIDE MOTIFS; POSITION-SPECIFIC SCORING MATRICES; RETROELEMENTS; TERMINAL REPEAT SEQUENCES; TRANSCRIPTIONAL ACTIVATION; VERTEBRATES;

EID: 84964603345     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/msv239     Document Type: Article

References (73)

1. Anwar F, Davenport MP, Ebrahimi D. (2013). Footprint of APOBEC3 on the genome of human retroelements. J Virol. 87: 8195-8204
2. Arias JF, Koyama T, Kinomoto M, Tokunaga K. (2012). Retroelements versus APOBEC3 family members: no great escape from the magnificent seven. Front Microbiol. 3: 275
3. Beale RCL, Petersen-Mahrt SK, Watt IN, Harris RS, Rada C, Neuberger MS. (2004). Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J Mol Biol. 337: 585-596
4. Bembom O. (2007). seqLogo: an R package for plotting DNA sequence logos. Available from: http://www.bioconductor.org/packages/re lease/bioc/html/seqLogo.html
5. Bishop KN, Holmes RK, Malim MH. (2006). Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J Virol. 80: 8450-8458
6. Bogerd HP, Tallmadge RL, Oaks JL, Carpenter S, Cullen BR. (2008). Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism. J Virol. 82: 11889-11901
7. Bogerd HP, Wiegand HL, Doehle BP, Lueders KK, Cullen BR. (2006). APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res. 34: 89-95
8. Browne EP, Allers C, Landau NR. (2009). Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent. Virology 387: 313-321
9. Carmi S, Church GM, Levanon EY. (2011). Large-scale DNA editing of retrotransposons accelerates mammalian genome evolution. Nat Commun. 2: 519
10. Conticello SG, Langlois M-A, Yang Z, Neuberger MS. (2007). DNA deamination in immunity: AID in the context of its APOBEC relatives. Adv Immunol. 94: 37-73
11. Conticello SG, Thomas CJF, Petersen-Mahrt SK, Neuberger MS. (2005). Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol Biol Evol. 22: 367-377
12. Cordaux R, Batzer MA. (2009). The impact of retrotransposons on human genome evolution. Nat Rev Genet. 10: 691-703
13. Cost GJ, Feng Q, Jacquier A, Boeke JD. (2002). Human L1 element targetprimed reverse transcription in vitro. EMBO J. 21: 5899-5910
14. Deininger PL, Moran JV, Batzer MA, Kazazian HH. (2003). Mobile elements and mammalian genome evolution. Curr Opin Genet Dev. 13: 651-658
15. Dewannieux M, Dupressoir A, Harper F, Pierron G, Heidmann T. (2004). Identification of autonomous IAP LTR retrotransposons mobile in mammalian cells. Nat Genet. 36: 534-539
16. Dewannieux M, Esnault C, Heidmann T. (2003). LINE-mediated retrotransposition of marked Alu sequences. Nat Genet. 35: 41-48
17. Deorrschuck E, Fischer N, Bravo IG, Hanschmann K-M, Kuiper H, Speotter A, Meoller R, Cichutek K, Meunk C, Teonjes RR (2011). Restriction of Porcine Endogenous Retrovirus by Porcine APOBEC3 Cytidine Deaminases. J Virol. 85: 3842-3857
18. Dutko JA, Scheafer A, Kenny AE, Cullen BR, Curcio MJ, Schafer A. (2005). Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr Biol. 15: 661-666
19. Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, Hance AJ, Heidmann T, Schwartz O. (2005). APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433: 430-433
20. Esnault C, Millet J, Schwartz O, Heidmann T. (2006). Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses. Nucleic Acids Res. 34: 1522-1531
21. Esnault C, Priet S, Ribet D, Heidmann O, Heidmann T. (2008). Restriction by APOBEC3 proteins of endogenous retroviruses with an extracellular life cycle: ex vivo effects and in vivo traces on the murine IAPE and human HERV-K elements. Retrovirology 5: 75
22. Fang X, Nevo E, Han L, Levanon EY, Zhao J, Avivi A, Larkin D, Jiang X, Feranchuk S, Zhu Y, et al. (2014). Genome-wide adaptive complexes to underground stresses in blind mole rats Spalax. Nat Commun. 5: 3966
23. Feschotte C. (2008). Transposable elements and the evolution of regulatory networks. Nat Rev Genet. 9: 397-405
24. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, et al. (2013). STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41: D808-D815
25. Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P, Zhang Y, Blankenberg D, Albert I, Taylor J, et al. (2005). Galaxy: a platform for interactive large-scale genome analysis. Genome Res. 15: 1451-1455
26. Guo F, Cen S, Niu M, Saadatmand J, Kleiman L. (2006). Inhibition of formula-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication. J Virol. 80: 11710-11722
27. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, Malim MH. (2003). DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809
28. Holmes RK, Malim MH, Bishop KN. (2007). APOBEC-mediated viral restriction: not simply editing?Trends Biochem Sci. 32: 118-128
29. Horn AV, Klawitter S, Held U, Berger A, Vasudevan AAJ, Bock A, Hofmann H, Hanschmann K-MO, Treosemeier J-H, Flory E, et al. (2014). Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity. Nucleic Acids Res. 42: 396-416
30. Hubbard T, Barker D, Birney E, Cameron G, Chen Y, Clark L, Cox T, Cuff J, Curwen V, Down T, et al. (2002). The Ensembl genome database project. Nucleic Acids Res. 30: 38-41
31. Ikeda T, Abd El, Galil KH, Tokunaga K, Maeda K, Sata T, Sakaguchi N, Heidmann T, Koito A. (2011). Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons. Nucleic Acids Res. 39: 5538-5554
32. Ikeda T, Ohsugi T, Kimura T, Matsushita S, Maeda Y, Harada S, Koito A. (2008). The antiretroviral potency of APOBEC1 deaminase from small animal species. Nucleic Acids Res. 36: 6859-6871
33. Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, Scott J, Navaratnam N. (2002). An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79: 285-296
34. Jónsson SR, Haché G, Stenglein MD, Fahrenkrug SC, Andrésdóttir V, Harris RS. (2006). Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins. Nucleic Acids Res. 34: 5683-5694
35. Kaiser SM, Emerman M. (2006). Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G. J Virol. 80: 875-882
36. Karolchik D. (2003). The UCSC Genome Browser database. Nucleic Acids Res. 31: 51-54
37. Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, Kent WJ. (2004). The UCSC Table Browser data retrieval tool. Nucleic Acids Res. 32: D493-D496
38. Kazazian HH. (2004). Mobile elements: drivers of genome evolution. Science 303: 1626-1632
39. Koito A, Ikeda T. (2011). Intrinsic restriction activity by AID/APOBEC family of enzymes against the mobility of retroelements. Mob Genet Elements. 1: 197-202
40. Koito A, Ikeda T. (2013). Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Front Microbiol. 4: 28
41. Langlois M-A, Neuberger MS. (2008). Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1. J Virol. 82: 4660-4664
42. LaRue RS, Andrésdóttir V, Blanchard Y, Conticello SG, Derse D, Emerman M, Greene WC, Jónsson SR, Landau NR, Leochelt M, et al. (2009). Guidelines for naming nonprimate APOBEC3 genes and proteins. J Virol. 83: 494-497
43. Lecossier D, Bouchonnet F, Clavel F, Hance AJ. (2003). Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300: 1112
44. Liddament MT, Brown WL, Schumacher AJ, Harris RS. (2004). APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr Biol. 14: 1385-1391
45. Lindic? N, Budic? M, Petan T, Knisbacher BA, Levanon EY, Lovśin N. (2013). Differential inhibition of LINE1 and LINE2 retrotransposition by vertebrate AID/APOBEC proteins. Retrovirology 10: 156
46. Luan DD, Korman MH, Jakubczak JL, Eickbush TH. (1993). Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell 72: 595-605
47. Luo K, Wang T, Liu B, Tian C, Xiao Z, Kappes J, Yu X-F. (2007). Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation. J Virol. 81: 7238-7248
48. MacDuff DA, Demorest ZL, Harris RS. (2009). AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity. Nucleic Acids Res. 37: 1854-1867
49. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. (2003). Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424: 99-103
50. Mariani R, Chen D, Schreofelbauer B, Navarro F, Keonig R, Bollman B, Meunk C, Nymark-McMahon H, Landau NR, Schrofelbauer B, et al. (2003). Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114: 21-31
51. Mbisa JL, Bu W, Pathak VK. (2010). APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms. J Virol. 84: 5250-5259
52. Miyagi E, Opi S, Takeuchi H, Khan M, Goila-Gaur R, Kao S, Strebel K. (2007). Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1. J Virol. 81: 13346-13353
53. Muckenfuss H, Hamdorf M, Held U, Perkovic M, Leower J, Cichutek K, Flory E, Schumann GG, Meunk C. (2006). APOBEC3 proteins inhibit human LINE-1 retrotransposition. J Biol Chem. 281: 22161-22172
54. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. (2000). Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563
55. Nellåker C, Keane TM, Yalcin B, Wong K, Agam A, Belgard TG, Flint J, Adams DJ, Frankel WN, Ponting CP. (2012). The genomic landscape shaped by selection on transposable elements across 18 mouse strains. Genome Biol. 13: R45
56. Newman ENC, Holmes RK, Craig HM, Klein KC, Lingappa JR, Malim MH, Sheehy AM. (2005). Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr Biol. 15: 166-170
57. Prado-Martinez J, Sudmant PH, Kidd JM, Li H, Kelley JL, Lorente-Galdos B, Veeramah KR, Woerner AE, O Connor TD, Santpere G, et al. (2013). Great ape genetic diversity and population history. Nature 499: 471-475
58. Prohaska KM, Bennett RP, Salter JD, Smith HC. (2014). The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions. Wiley Interdiscip Rev RNA. 5: 493-508
59. Refsland EW, Harris RS. (2013). The APOBEC3 family of retroelement restriction factors. Curr Top Microbiol Immunol. 371: 1-27
60. Sawyer SL, Emerman M, Malik HS. (2004). Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2: E275
61. Schumacher AJ, Haché G, Macduff DA, Brown WL, Harris RS. (2008). The DNA deaminase activity of human APOBEC3G is required for Ty1, Mus D, and human immunodeficiency virus type 1 restriction. J Virol. 82: 2652-2660
62. Schumacher AJ, Nissley DV, Harris RS. (2005). APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc Natl Acad Sci U S A. 102: 9854-9859
63. Severi F, Chicca A, Conticello SG. (2011). Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function. Mol Biol Evol. 28: 1125-1129
64. Smit AF. (1999). Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr Opin Genet Dev. 9: 657-663
65. Smit AFA, Hubley R, Green P. RepeatMasker Open-3.0, 1996-2010. Available from: http://www.repeatmasker.org
66. Smith HC, Bennett RP, Kizilyer A, McDougall WM, Prohaska KM. (2012). Functions and regulation of the APOBEC family of proteins. Semin Cell Dev Biol. 23: 258-268
67. Stenglein MD, Harris RS. (2006). APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independentmechanism. J Biol Chem. 281: 16837-16841
68. Suspène R, Aynaud M-M, Guétard D, Henry M, Eckhoff G, Marchio A, Pineau P, Dejean A, Vartanian J-P, Wain-Hobson S. (2011). Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci U S A. 108: 4858-4863
69. Tsirigos A, Rigoutsos I. (2009). Alu and b1 repeats have been selectively retained in the upstream and intronic regions of genes of specific functional classes. PLoS Comput Biol. 5: e1000610
70. Wang T, Zeng J, Lowe CB, Sellers RG, Salama SR, Yang M, Burgess SM, Brachmann RK, Haussler D. (2007). Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53. Proc Natl Acad Sci U S A. 104: 18613-18618
71. Zaranek AW, Levanon EY, Zecharia T, Clegg T, Church GM. (2010). A survey of genomic traces reveals a common sequencing error, RNA editing, and DNA editing. PLoS Genet. 6: e1000954
72. Zhang G, Li C, Li Q, Li B, Larkin DM, Lee C, Storz JF, Antunes A, Greenwold MJ, Meredith RW, et al. (2014). Comparative genomics reveals insights into avian genome evolution and adaptation. Science 346: 1311-1320
73. Zhang J, Webb DM. (2004). Rapid evolution of primate antiviral enzyme APOBEC3G. Hum Mol Genet. 13: 1785-1791